New treatments and novel insights of thymic epithelial tumors and mediastinal germ cell tumors (Ongoing)

Posted On 2021-03-10 14:23:12



The series on “New treatments and novel insights of thymic epithelial tumors and mediastinal germ cell tumors” is edited by Drs Margaret Ottaviano & Giovannella Palmieri, Rare Tumors Reference Center, University Federico II, Naples, Italy.

Margaret Ottaviano, MD
Coordinating Rare Tumors Reference Center of Campania Region, University Hospital Federico II, Naples, Italy

Dr. Ottaviano is consultant in medical oncology at the Ospedale del Mare, ASL Napoli 1, in Naples, Italy. She is concluding the PhD in “Advanced biomedical and surgical therapies” at the Department of Clinical Medicine and Surgery of Università degli studi di Napoli Federico II, carrying on a research project focused on the immunological mechanisms involved in platinum-resistant rare malignancies such as thymic epithelial tumors and testicular germ cell tumors. She is also the regional coordinator of the Rare Tumors Reference Center of Naples and the young section’s coordinator of the SCITO (Oncological Immunotherapy Society of Campania Region).

Her field of expertise includes rare solid tumors of adults, with a special focus on rare thoracic tumors, neuroendocrine tumors, endocrine tumors and rare genito-urinary tumors. She is a recipient of several ITMIG (International Thymic Malignancy Interest Group) awards thanks to her commitment for thymic malignancies: ITMIG Seoul 2018 Best Poster Presentation; ITMIG Toronto 2019 Best Poster Presentation. The latest research works of Dr. Ottaviano will be presented as oral presentations at the IASLC 2020 World Conference on Lung Cancer | Singapore, Worldwide Virtual Event, which will be held on January 2021. She has several publications on innovative treatments, radiologic-response correlation and immunological dysregulation of thymic epithelial tumors.

Giovannella Palmieri, MD
Rare Tumors Reference Center, University Federico II, Naples, Italy

Dr. Giovannella Palmieri has been a MD at AOU Federico II - Faculty of Medicine and Surgery of the University Federico II, Naples since 1983 and was Head of Rare Tumors Unit from 2003 to 2016. She has been the Scientific Director CRTR (Rare tumors reference center, Campania Region) since 2009.

She received her MD degree from University of Naples "Federico II", Naples in 1973 and specialized in Infectious diseases in 1976, later specialized in Internal Medicine in 1980 and in Immunology in 1983.

She has carried out many researches about non - Hodgkin lymphoma, sarcoma, epithelial tumors and biological therapy for cancer. She takes part in different research projects in the field of rare tumors, dealing with particularly epithelial tumors with associated syndromes, sarcomas, neuroendocrine tumors and germ cell tumors. Moreover, she is patient coordinator in the oncological unit of AOU FEDERICO II as concerns the excellence center of ENETS.

She's author of different scientific articles and active member of International thymic malignancies interest group (ITMIG), and Italian association rare tumours (IART). She’s President of Italian Germinal Group (IGG); member of American Society of Clinical Oncology (ASCO); member of European Society of Medical Oncology (ESMO); member of International Association of Study for Lung Cancers (IASLC).

Due to high expertise in rare tumors and her scientific role in CRTR, she's substitutive representative in the application of the reference center to ERN (European Reference Network)

Series outline:

  1. Introduction to the series 
  2. Mediastinal germ cell tumors: where we are and where we are going 
  3. Genomic features of mediastinal germ cell tumors 
  4. Standard dose versus high dose chemotherapy in mediastinal germ cell tumors 
  5. Rare histological subtype of thymic epithelial tumors
  6. High dose chemotherapy in Mediastinal germ cell tumors during COVID-19 pandemic 
  7. Immune check point inhibitors in thymic epithelial tumors and mediastinal germ cell tumors
  8. Multidisciplinar approach for thymic epithelial tumors and mediastinal germ cell tumors during COVID-19 pandemic 
  9. The European Reference Center Experience for the management of rare thoracic cancers 
  10. Histological aggressivness features of mediastinal germ cell tumors
  11. Radiotherapy in mediastinal syndrome

Disclosure:
The series “New treatments and novel insights of thymic epithelial tumors and mediastinal germ cell tumors” was commissioned by the editorial office, Mediastinum without any sponsorship or funding. Drs Margaret Ottaviano & Giovannella Palmieri are serving as the unpaid Guest Editors for the series.